[ 9 ] analyzed data from the MAGIC-MT, EMBOLISE, and STEM trials and found that MMAE reduced symptomatic progression or recurrence overall, although the result narrowly missed statistical significance (risk ratio (RR) 0.50, 95% CI 0.23–1.06; p = 0.058).
← all excerpts
Chronic Subdural Hematoma: Pathophysiology, Diagnosis, and the Emerging Role of Middle Meningeal Artery Embolization.
2
0.0580
0.0580
The sentences
21.0%), although this difference did not reach statistical significance.